SOLVENT-DEPENDENT AND CONCENTRATION-DEPENDENT MOLECULAR-INTERACTIONS OF TAXOL (PACLITAXEL)

被引:54
作者
BALASUBRAMANIAN, SV
ALDERFER, JL
STRAUBINGER, RM
机构
[1] SUNY AMHERST,DEPT PHARMACEUT,AMHERST,NY 14260
[2] ROSWELL PK CANC INST,DEPT BIOPHYS,BUFFALO,NY 14263
关键词
D O I
10.1002/jps.2600831021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Taxol (paclitaxel) is a promising anticancer agent that has been approved for the treatment of ovarian cancer and is under investigation for the therapy of other tumors. Paclitaxel is poorly soluble in water, and information on its physical behavior in hydrophilic and hydrophobic environments is limited. Circular dichroism (CD) and nuclear magnetic resonance spectroscopy were used to investigate the effect of solvent and drug concentration on the solution conformation of paclitaxel. CD is sensitive to paclitaxel's environment, owing to the presence of effective chromophores in the vicinity of several chiral centers. It was found that (i) the conformation of the paclitaxel side chain depends on the polarity of the solvent and (ii) paclitaxel has a tendency to undergo concentration-dependent aggregation in solvents such as chloroform. To account for the observations, a model is proposed in which paclitaxel molecules are held together in stacks by intermolecular hydrogen bonds involving all four exchangeable protons. Intermolecular interactions and self-association of paclitaxel may have impact not only on the physical stability of the drug in existing formulations or investigational vehicles but also on the effect of paclitaxel in the stabilization of cellular microtubules.
引用
收藏
页码:1470 / 1476
页数:7
相关论文
共 34 条
  • [1] Adams J D, 1993, J Natl Cancer Inst Monogr, P141
  • [2] SOLUTION CONFORMATION OF IONOPHORE A23187 AND ITS MAGNESIUM SALT
    ANTEUNIS, MJO
    [J]. BIOORGANIC CHEMISTRY, 1977, 6 (01) : 1 - 11
  • [3] H-1-NMR AND C-13-NMR ASSIGNMENTS FOR TAXOL, 7-EPI-TAXOL, AND CEPHALOMANNINE
    CHMURNY, GN
    HILTON, BD
    BROBST, S
    LOOK, SA
    WITHERUP, KM
    BEUTLER, JA
    [J]. JOURNAL OF NATURAL PRODUCTS, 1992, 55 (04): : 414 - 423
  • [4] DEBRABENDER M, 1981, P NATL ACAD SCI USA, V78, P508
  • [5] DEMARCANO DPD, 1970, J CHEM SOC CHEM COMM, P582
  • [6] DONEHOWER RC, 1987, CANCER TREAT REP, V71, P1171
  • [7] CHARACTERIZATION OF TAXOL IN METHYLENE-CHLORIDE BY NMR-SPECTROSCOPY
    FALZONE, CJ
    BENESI, AJ
    LECOMTE, JTJ
    [J]. TETRAHEDRON LETTERS, 1992, 33 (09) : 1169 - 1172
  • [8] GREM JL, 1987, CANCER TREAT REP, V71, P1179
  • [9] STRUCTURE OF A SYNTHETIC TAXOL PRECURSOR - N-TERT-BUTOXYCARBONYL-10-DEACETYL-N-DEBENZOYLTAXOL
    GUERITTEVOEGELEIN, F
    GUENARD, D
    MANGATAL, L
    POTIER, P
    GUILHEM, J
    CESARIO, M
    PASCARD, C
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1990, 46 : 781 - 784
  • [10] RELATIONSHIPS BETWEEN THE STRUCTURE OF TAXOL ANALOGS AND THEIR ANTIMITOTIC ACTIVITY
    GUERITTEVOEGELEIN, F
    GUENARD, D
    LAVELLE, F
    LEGOFF, MT
    MANGATAL, L
    POTIER, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (03) : 992 - 998